We are live on ! Find out more
EP

Eversept Partners Portfolio holdings

AUM $1.93B
1-Year Est. Return 160.8%
This Fund
S&P 500
This Quarter Est. Return
+17.28%
1 Year Est. Return
+160.8%
3 Year Est. Return
+321.09%
5 Year Est. Return
+420.29%
10 Year Est. Return
–
AUM
$1.14B
AUM Growth
-$43.5M
Cap. Flow
+$1.54M
Cap. Flow %
0.14%
Top 10 Hldgs %
61.62%
Holding
73
New
4
Increased
21
Reduced
29
Closed
16

Top Buys

Rank Stock Value
1
ARGX icon
argenx
ARGX
+$37.9M
2
INSP icon
Inspire Medical Systems
INSP
+$25.6M
3
IMGN
Immunogen Inc
IMGN
+$14.9M
4
RVTY icon
Revvity
RVTY
+$14.5M
5
SNDX icon
Syndax Pharmaceuticals
SNDX
+$12.1M

Top Sells

Rank Stock Value
1
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$23.8M
2
DHR icon
Danaher
DHR
+$16.2M
3
NTRA icon
Natera
NTRA
+$12M
4
AMRX icon
Amneal Pharmaceuticals
AMRX
+$11.2M
5
GSK icon
GSK
GSK
+$10.3M

Sector Composition

Rank Sector Weight
1 Healthcare 89.59%
2 Miscellaneous 10.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NTRA icon
1
Natera
NTRA
$47B
$141M 12.39%
2,251,588
-241,048
-10% -$12M
GSK icon
2
GSK
GSK
$102B
$110M 9.68%
2,972,954
-286,388
-9% -$10.3M
SNDX icon
3
Syndax Pharmaceuticals
SNDX
$1.74B
$73.1M 6.42%
3,383,244
+786,999
+30% +$12.1M
INSP icon
4
Inspire Medical Systems
INSP
$1.78B
$71.4M 6.28%
351,116
+158,098
+82% +$25.6M
TEVA icon
5
Teva Pharmaceuticals
TEVA
$42.5B
$64.3M 5.64%
6,154,354
-797,731
-11% -$7.45M
QQQ icon
6
PUT
Invesco QQQ Trust
QQQ
$489B
$61.4M 5.4%
150,000
-250,000
-63% -$94.9M
SPY icon
7
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$825B
$57M 5.01%
120,000
-120,000
-50% -$53.5M
UTHR icon
8
United Therapeutics
UTHR
$22.1B
$54.1M 4.76%
246,234
-21,669
-8% -$4.99M
TECH icon
9
Bio-Techne
TECH
$11.3B
$35.9M 3.15%
465,307
+79,418
+21% +$5.23M
HQY icon
10
HealthEquity
HQY
$7.97B
$32.8M 2.88%
494,919
+156,403
+46% +$10.8M
ARGX icon
11
argenx
ARGX
$64B
$32.7M 2.87%
85,832
+81,267
+1,780% +$37.9M
HCA icon
12
HCA Healthcare
HCA
$90.5B
$31.1M 2.73%
114,805
+4,732
+4% +$1.17M
CLDX icon
13
Celldex Therapeutics
CLDX
$3.07B
$29.9M 2.63%
754,107
+165,964
+28% +$4.88M
VERA icon
14
Vera Therapeutics
VERA
$2.46B
$29.5M 2.59%
1,914,830
+436,341
+30% +$5.54M
CYH icon
15
Community Health Systems
CYH
$413M
$22.6M 1.99%
7,231,126
+85,038
+1% +$229K
IMGN
16
DELISTED
Immunogen Inc
IMGN
$22.2M 1.95%
+748,950
New +$14.9M
RVTY icon
17
Revvity
RVTY
$14.4B
$20M 1.76%
183,059
+150,361
+460% +$14.5M
IONS icon
18
Ionis Pharmaceuticals
IONS
$10.1B
$16.4M 1.44%
324,654
+72,208
+29% +$3.46M
PCVX icon
19
Vaxcyte
PCVX
$8.9B
$14.7M 1.29%
233,839
+43,409
+23% +$2.25M
SWAV
20
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
$14.4M 1.27%
75,822
-8,640
-10% -$1.63M
THC icon
21
Tenet Healthcare
THC
$21.5B
$14.2M 1.24%
+187,265
New +$11.9M
PTGX icon
22
Protagonist Therapeutics
PTGX
$9.34B
$12.3M 1.08%
538,074
+251,326
+88% +$4.4M
ILMN icon
23
Illumina
ILMN
$32.6B
$12.1M 1.06%
89,039
-82,413
-48% -$9.51M
TARO
24
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
$10.7M 0.94%
255,988
+665
+0.3% +$24.5K
KRYS icon
25
Krystal Biotech
KRYS
$10.4B
$10M 0.88%
80,798
-27,973
-26% -$3.1M
1
2 3

Similar funds

SWM
Segment Wealth Management Houston, Texas $1.93B AUM 29.24% 1-Year Est. Return
RIA
Regal Investment Advisors Kentwood, Michigan $1.92B AUM 23.13% 1-Year Est. Return
SI
Standard Investments New York $1.93B AUM 6.23% 1-Year Est. Return
SG
Sourcerock Group Denver, Colorado $1.92B AUM 45.54% 1-Year Est. Return
DCP
Distillate Capital Partners Chicago, Illinois $1.92B AUM 5.31% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
GIA
Guyasuta Investment Advisors Pittsburgh, Pennsylvania $1.94B AUM 32.92% 1-Year Est. Return
MFM
MHR Fund Management New York $1.92B AUM 119.57% 1-Year Est. Return

Eversept Partners's Q4 2023 Portfolio in Review

As of Q4 2023, Eversept Partners held 73 positions worth $1.14B, down 3.7% from $1.18B the previous quarter. Its ten largest holdings account for 62% of the portfolio.

Eversept Partners's Q4 2023 filing shows 4 new, 21 increased, 29 reduced and 16 closed positions. Its largest new stake was Immunogen Inc: 748,950 shares worth $22.2M. The largest sale was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $23.8M.

By sector, the portfolio is most concentrated in Healthcare at 90% of assets, up from 76% a quarter earlier, followed by Miscellaneous.

  • Eversept Partners's largest Q4 2023 buy was Immunogen Inc: 748,950 shares worth $22.2M.
  • Eversept Partners added most to argenx in Q4 2023, an estimated $37.9M increase.
  • Eversept Partners's biggest Q4 2023 reduction was Danaher, cutting an estimated $16.2M.
  • Eversept Partners fully exited Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2023, selling an estimated $23.8M.
  • Eversept Partners's ten largest holdings make up 62% of its $1.14B portfolio in Q4 2023.
  • Eversept Partners opened 4 new positions and closed 16 in Q4 2023.
  • Eversept Partners's portfolio value fell 3.7% quarter-over-quarter to $1.14B.

Based on Eversept Partners's 13F filing for Q4 2023, filed 14 Feb 2024.